Medicare Experts Mull Idea Of U.S. Comparative Effectiveness Review Agency
Executive Summary
Impressed by the success of the UK's comparative effectiveness health care agency NICE, Medicare payment expert Gail Wilensky is pushing for a similar body in the U.S. - and at least one major stakeholder, Johnson & Johnson, appears willing to entertain the idea
You may also be interested in...
Drug Price Versus Value: British Pharma Plans Public Debate In November
Having called for a public debate on how the United Kingdom values and provides access to new medicines, the Association of the British Pharmaceutical Industry is organizing to make it happen
Drug Price Versus Value: British Pharma Plans Public Debate In November
Having called for a public debate on how the United Kingdom values and provides access to new medicines, the Association of the British Pharmaceutical Industry is organizing to make it happen
Part D Success Will Enhance Pharma’s Political Effectiveness, Execs Predict
The pharmaceutical industry will draw on its achievements in helping develop the Medicare drug benefit as it faces health care reform and other political challenges following the upcoming presidential election, top Merck and Schering-Plough executives predict